Sentry Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sentry Investment Management LLC

$238 Million
Q3 2024

A detailed history of Sentry Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sentry Investment Management LLC holds 512 shares of REGN stock, worth $387,486. This represents 0.23% of its overall portfolio holdings.

Number of Shares

512

Previous 512 -0.0%

Holding current value

$387,486

Previous $538,000 -0.0%

% of portfolio

0.23%

Previous 0.24%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$883.2 - $1071.19 $42,393 - $51,417	-48 Reduced 8.57%	512 $538,000
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $46,510 - $52,902	-60 Reduced 9.68%	560 $492,000
Q3 2023 Nov 03, 2023	SELL	$692.45 - $844.37 $99,712 - $121,589	-144 Reduced 18.85%	620 $510,000
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $41,301 - $48,990	59 Added 8.37%	764 $549,000
Q1 2023 Apr 26, 2023	SELL	$680.49 - $826.97 $27,900 - $33,905	-41 Reduced 5.5%	705 $579,000
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $24,000 - $26,057	34 Added 4.78%	746 $538,000
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $76,220 - $102,698	-139 Reduced 16.33%	712 $421,000
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $85,102 - $99,875	-143 Reduced 14.39%	851 $594,000
Q3 2021 Nov 03, 2021	SELL	$574.03 - $680.96 $83,234 - $98,739	-145 Reduced 12.73%	994 $602,000
Q1 2021 Apr 21, 2021	SELL	$446.73 - $548.2 $2.43 Million - $2.98 Million	-5,445 Reduced 82.7%	1,139 $539,000
Q3 2020 Nov 05, 2020	BUY	$544.75 - $658.21 $849,265 - $1.03 Million	1,559 Added 31.02%	6,584 $3.69 Million
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $140,596 - $183,517	285 Added 6.01%	5,025 $3.13 Million
Q3 2019 Nov 08, 2019	BUY	$273.46 - $318.39 $60,708 - $70,682	222 Added 4.91%	4,740 $1.32 Million
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $149,204 - $176,267	-401 Reduced 8.15%	4,518 $1.86 Million
Q4 2018 Feb 11, 2019	SELL	$335.82 - $403.04 $43,320 - $51,992	-129 Reduced 2.56%	4,919 $1.84 Million
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $11,384 - $13,799	40 Added 0.8%	5,048 $1.74 Million
Q1 2018 May 02, 2018	SELL	$315.82 - $393.78 $254,866 - $317,780	-807 Reduced 13.88%	5,008 $1.73 Million
Q2 2017 Aug 21, 2017	BUY	N/A	5,815	5,815 $2.86 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.

Account

Sentry Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History